Finance

Lists
Q1 2027 earnings • released • Revenue beat +11.42%
See results
YATHARTH:NSE
Yatharth Hospital & Trauma Cre Srvcs Ltd
₹834.45
-1.26%
(-10.65) 1D
Aug 14, 9:26:37 AM GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for YATHARTH...
Open
₹845.10
High
₹847.00
Low
₹832.80
Mkt. cap
80.43B
Avg. vol.
0.00
Volume
34.30K
Dividend
0.06%
Quarterly dividend
₹0.12
P/E ratio
44.39
52-wk high
₹919.50
52-wk low
₹538.25
EPS
₹18.80
No. of employees
5K
Open
₹845.10
High
₹847.00
Low
₹832.80
Mkt. cap
80.43B
Avg. vol.
0.00
Volume
34.30K
Dividend
0.06%
Quarterly dividend
₹0.12
P/E ratio
44.39
52-wk high
₹919.50
52-wk low
₹538.25
EPS
₹18.80
No. of employees
5K
News stories
From web sources and news partners
Profile
Yatharth Hospital & Trauma Care Services Ltd is an Indian for-profit private hospital chain of North India. It operates 8 hospitals with more than 2500 beds in four states of India. It was founded by Dr. Ajay Kumar Tyagi and Dr. Kapil Kumar in 2008. All of its hospitals are accredited by NABH. Its facility in Greater Noida West is the first and only hospital in Uttar Pradesh to be accredited by Joint Commission International. Wikipedia
About Yatharth Hospital & Trauma Cre Srvcs Ltd
CEO-
Employees4.9K
Founded2008
Headquarters-
SectorHealth care provider
Last report
Aug 11, 2026
Fiscal period
Q1 2027
EPS / Est. (INR)
- / -
Revenue / Est. (INR)
3.97B / 3.56B
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
2.79B
3.20B
3.42B
3.97B
Cost of goods sold
1.10B
1.26B
1.32B
1.47B
Cost of revenue
1.10B
1.26B
1.32B
1.47B
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-
-
-
-
Operating expense
1.24B
1.44B
1.59B
1.82B
Total operating expenses
2.34B
2.70B
2.92B
3.29B
Operating income
455.91M
502.89M
499.15M
677.97M
Other non operating income
94.89M
78.25M
71.08M
-
EBT including unusual items
548.23M
570.97M
519.52M
612.05M
EBT excluding unusual items
548.23M
570.97M
519.52M
612.05M
Income tax expense
135.70M
140.14M
72.54M
157.82M
Effective tax rate
24.75%
24.54%
13.96%
25.79%
Other operating expenses
1.05B
1.20B
1.29B
1.54B
Net income
412.42M
453.51M
475.20M
470.61M
Net profit margin
14.76%
14.15%
13.91%
11.85%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.57M
-10.17M
-50.71M
-65.92M
Net interest expenses
-2.57M
-10.17M
-50.71M
-65.92M
Depreciation and amortization charges
189.31M
239.60M
299.96M
282.38M
EBITDA
625.16M
639.36M
718.66M
897.48M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more
Google apps